Deep phenotyping of health-disease continuum in the Human Phenotype Project

Lee Reicher, Smadar Shilo, Anastasia Godneva, Guy Lutsker, Liron Zahavi, Saar Shoer, David Krongauz, Michal Rein, Sarah Kohn, Tomer Segev, Yishay Schlesinger, Daniel Barak, Zachary Levine, Ayya Keshet, Rotem Shaulitch, Maya Lotan-Pompan, Matan Elkan, Yeela Talmor-Barkan, Yaron Aviv, Maya DadianiYonatan Tsodyks, Einav Nili Gal-Yam, Haim Leibovitzh, Lael Werner, Roie Tzadok, Nitsan Maharshak, Shin Koga, Yulia Glick-Gorman, Chani Stossel, Maria Raitses-Gurevich, Talia Golan, Raja Dhir, Yotam Reisner, Adina Weinberger, Hagai Rossman, Le Song, Eric P. Xing*, Eran Segal*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

The Human Phenotype Project (HPP) is a large-scale deep-phenotype prospective cohort. To date, approximately 28,000 participants have enrolled, with more than 13,000 completing their initial visit. The project is aimed at identifying novel molecular signatures with diagnostic, prognostic and therapeutic value, and at developing artificial intelligence (AI)-based predictive models for disease onset and progression. The HPP includes longitudinal profiling encompassing medical history, lifestyle and nutrition, anthropometrics, blood tests, continuous glucose and sleep monitoring, imaging and multi-omics data, including genetics, transcriptomics, microbiome (gut, vaginal and oral), metabolomics and immune profiling. Analysis of these data highlights the variation of phenotypes with age and ethnicity and unravels molecular signatures of disease by comparison with matched healthy controls. Leveraging extensive dietary and lifestyle data, we identify associations between lifestyle factors and health outcomes. Finally, we present a multi-modal foundation AI model, trained using self-supervised learning on diet and continuous-glucose-monitoring data, that outperforms existing methods in predicting disease onset. This framework can be extended to integrate other modalities and act as a personalized digital twin. In summary, we present a deeply phenotyped cohort that serves as a platform for advancing biomarker discovery, enabling the development of multi-modal AI models and personalized medicine approaches.
Original languageEnglish
Pages (from-to)3191-3203
Number of pages22
JournalNature Medicine
Volume31
Issue number9
DOIs
Publication statusPublished Online - 15 Jul 2025

Funding

We thank the members of the Segal group for fruitful discussions. E.S. is supported by the Crown Human Genome Center; the Larson Charitable Foundation New Scientist Fund; the Else Kroner Fresenius Foundation; the White Rose International Foundation; the Ben B. and Joyce E. Eisenberg Foundation; the Nissenbaum Family; Marcos Pinheiro de Andrade and Vanessa Buchheim; Lady Michelle Michels; Aliza Moussaieff; and grants funded by the Minerva Foundation, with funding from the Federal German Ministry for Education and Research and by the European Research Council and the Israel Science Foundation.

All Science Journal Classification (ASJC) codes

  • General Medicine
  • General Biochemistry,Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Deep phenotyping of health-disease continuum in the Human Phenotype Project'. Together they form a unique fingerprint.

Cite this